Does TACROLIMUS\TACROLIMUS ANHYDROUS Cause Chronic obstructive pulmonary disease? 6 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Chronic obstructive pulmonary disease have been filed in association with TACROLIMUS\TACROLIMUS ANHYDROUS. This represents 0.1% of all adverse event reports for TACROLIMUS\TACROLIMUS ANHYDROUS.
6
Reports of Chronic obstructive pulmonary disease with TACROLIMUS\TACROLIMUS ANHYDROUS
0.1%
of all TACROLIMUS\TACROLIMUS ANHYDROUS reports
1
Deaths
5
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From TACROLIMUS\TACROLIMUS ANHYDROUS?
Of the 6 reports, 1 (16.7%) resulted in death, 5 (83.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS\TACROLIMUS ANHYDROUS. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS\TACROLIMUS ANHYDROUS Cause?
Off label use (708)
Death (321)
Transplant rejection (278)
Diarrhoea (257)
Pyrexia (243)
Alopecia (232)
Drug ineffective (198)
Transplant dysfunction (198)
Hospitalisation (194)
Pneumonia (193)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which TACROLIMUS\TACROLIMUS ANHYDROUS Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
TACROLIMUS\TACROLIMUS ANHYDROUS vs TADALAFIL
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFAMIDIS
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFASITAMAB
TACROLIMUS\TACROLIMUS ANHYDROUS vs TAFASITAMAB-CXIX